Clinical Trials & Biospecimen Programs Manager

Rutgers University; New Brunswick (NJ); On-site; USD 111,000 - 170,000; Full time

Job summary

Rutgers University is seeking a Project Manager for the Rutgers Cancer Institute within Administration and Planning. The role oversees planning and execution of research programs, including clinical trials and biospecimen activities, coordinating with multiple stakeholders to translate priorities into actionable project plans and performance metrics.

The candidate will develop charters, implementation plans, milestones, and indicators, collaborate across investigators, OHRS, and regulatory

Qualifications

• Bachelor's degree in a relevant field and five years of related experience (or Master's with three years) is required.
• Two years of supervisory experience and proficiency with Microsoft Office and data reporting tools.
• Ph.D. candidate is preferred.

Responsibilities

• Lead planning and execution of research program activities including clinical trials, lab research, and biospecimen workflows.
• Develop program charters, implementation plans, milestones, resources, and performance indicators.
• Collaborate with investigators, clinical teams, OHRS, and regulatory offices to advance projects and remove barriers.
• Create dashboards and reporting frameworks using CRMS and other data sources to monitor performance.

Skills

Project management

Stakeholder coordination

Data analysis

Education

Bachelor's degree in a relevant field

Master's degree

Ph.D. candidate

Tools

Microsoft Office

Database/reporting tools

Job description

Rutgers University is seeking a Project Manager for the Rutgers Cancer Institute within Administration and Planning. The role oversees planning and execution of research programs, including clinical trials and biospecimen activities, coordinating with multiple stakeholders to translate priorities into actionable project plans and performance metrics.

The candidate will develop charters, implementation plans, milestones, and indicators, collaborate across investigators, OHRS, and regulatory